Pazufloxacin
Alternative Names: Pasil; Pasil Injection; Pazucross; Pazufloxacin Injection; Pazufloxacin mesilate; T 3761; T 3762Latest Information Update: 29 Oct 2018
Price :
$50 *
At a glance
- Originator Toyama Chemical
- Developer FUJIFILM Toyama Chemical; Mitsubishi Tanabe Pharma Corporation
- Class Anti-infectives; Antibacterials; Fluoroquinolones; Oxazines; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Bacterial infections; Legionnaires' disease; Pneumococcal infections; Sepsis
Most Recent Events
- 23 Jul 2010 Launched for Pneumococcal infections in Japan (IV)
- 23 Jul 2010 Launched for Sepsis in Japan (IV)
- 23 Jul 2010 Registered for Pneumococcal infections in Japan (IV)